Page 805 - medicina-integrativa_compress

822 PARTE II, SECCIÓN 13 CÁNCER

25. Bradley CJ, Given CW, Roberts C, et al: Race, socioeconomic status, 53. Ambrosone CB, McCann SE, Freudenheim JL, et al: Breast cancer
and breast cancer treatment and survival. J Natl Cancer Inst 94:490- risk in premenopausal women is inversely associated with
496, 2002. consumption of broccoli, a source of isothiocyanates, but is not
26. Chen WY, Hankinson SE, Schnitt SJ, et al: Association of hormone modified by GST genotype. J Nutr 134:1134-1138, 2004.
replacement therapy to estrogen and progesterone receptor status in 54. Fowke JH, Chung FL, Jin G, et al: Urinary isothiocyanate levels,
invasive breast carcinoma. Cancer 101:1490-1500, 2004. brassica, and human breast cancer. Cancer Res 63:3980-3986, 2003.
27. Collaborative Group on Hormonal Factors in Breast Cancer: 55. Terry P, Wolk A, Persson I, et al: Brassica vegetables and breast
Familial breast cancer: Collaborative reanalysis of individual data cancer risk. JAMA 285:2975-2977, 2001.
from 52 epidemiological studies including 58,209 women with 56. Reed GA, Peterson KS, Smith HJ, et al: A phase I study of indole-
breast cancer and 101,986 women without the disease. Lancet 3-carbinol in women: Tolerability and effects. Cancer Epidemiol
358:1389-1399, 2001. Biomarkers Prev 14:1953-1960, 2005.
28. Michels KB, Ekbom A: Caloric restriction and incidence of breast 57. Brignall MS: Prevention and treatment of cancer with indole-
cancer. JAMA 291:1226-1230, 2004. 3-carbinol. Altern Med Rev 6:580-589, 2001.
29. Lajous M, Willett W, Lazcano-Ponce E, et al: Glycemic load, 58. Terry PD, Rohan TE, Wolk A: Intakes of fish and marine fatty acids
glycemic index, and the risk of breast cancer among Mexican and the risks of cancer of the breast and prostate and of other
women. Cancer Causes Control 16:1165-1169, 2005. hormone-related cancers: A review of the epidemiologic evidence.
30. Cocca C, Nunez M, Gutierrez A, et al: IGF-I in mammary Am J Clin Nutr 77:532-543, 2003.
tumorigenesis and diabetes. Anticancer Res 24:2953-2965, 2004. 59. Menendez JA, Vellon L, Colomer R, et al: Effect of gamma-linolenic
31. Willett WC: Diet and cancer: One view at the start of the acid on transcriptional activity of the Her-2/neu (erbB-2) oncogene.
millennium. Cancer Epidemiol Biomarkers Prev 10:3-8, 2001. J Natl Cancer Inst 97:1611-1615, 2005.
32. Lagerros YT, Hsieh SF, Hsieh CC: Physical activity in adolescence 60. Menendez JA, Vellon L, Colomer R, et al: Oleic acid, the main
and young adulthood and breast cancer risk: A quantitative review. monounsaturated fatty acid of olive oil, suppresses Her-2/neu (erbB-2)
Eur J Cancer Prev 13:5-12, 2004. expression and synergistically enhances the growth inhibitory effects
33. Lee IM: Physical activity and cancer prevention—data from of trastuzumab (Herceptin) in breast cancer cells with Her-2/neu
epidemiologic studies. Med Sci Sports Exerc 35:1823-1827, 2003. oncogene amplification. Ann Oncol 16:359-371, 2005.
34. Friedenreich CM: Physical activity and breast cancer risk: The effect 61. Branca F, Lorenzetti S: Health effects of phytoestrogens. Forum Nutr
of menopausal status. Exerc Sport Sci Rev 32:180-184, 2004. (57):100-111, 2005.
35. Bentz AT, Schneider CM, Westerlind KC: The relationship between 62. Low Dog,T, Micozzi M: Women's Health in Complementary and
physical activity and 2-hydroxyestrone, 16alpha-hydroxyestrone, and Integrative Medicine: A Clinical Guide. Philadelphia, Elsevier, 2005.
the 2/16 ratio in premenopausal women (United States). Cancer 63. Natural Standard Research Collaboration: An evidence-based
Causes Control 16:455-461, 2005. systematic review of soy. www.naturalstandard.com/
36. Malin A, Matthews CE, Shu XO, Cai H: Energy balance and breast 64. Limer JL, Speirs V: Phyto-oestrogens and breast cancer
cancer risk. Cancer Epidemiol Biomarkers Prev 14:1496-1501, 2005. chemoprevention. Breast Cancer Res 6:119-127, 2004.
37. Megdal SP, Kroenke CH, Laden F, et al: Night work and breast 65. Piersen CE: Phytoestrogens in botanical dietary supplements:
cancer risk: A systematic review and meta-analysis. Eur J Cancer Implications for cancer. Integr Cancer Ther 2:120-138, 2003.
41:2023-2032, 2005. 66. Thompson LU, Chen JM, Li T, et al: Dietary flaxseed alters tumor
38. Hanson J: Increased breast cancer risk among women who work biological markers in postmenopausal breast cancer. Clin Cancer
predominantly at night. Epidemiology 12:74-77, 2001. Res 11:3828-3835, 2005.
39. Schernhammer ES, Rosner B, Willett W, et al: Epidemiology of 67. Slavin J: Why whole grains are protective: Biological mechanisms.
urinary melatonin in women and its relation to other hormones and Proc Nutr Soc 62:129-134, 2003.
night work. Cancer Epidemiol Biomarkers Prev 13:936-943, 2004. 68. Ramachandran C, Rodriguez S, Ramachandran R, et al: Expression
40. Starek A: Estrogens and organochlorine xenoestrogens and breast profiles of apoptotic genes induced by curcumin in human breast
cancer risk. Int J Occup Med Environ Health 16:113-124, 2003. cancer and mammary epithelial cell lines. Anticancer Res 25:3293-
41. Jaga K, Dharmani C: The epidemiology of pesticide exposure and 3302, 2005.
cancer: A review. Rev Environ Health 20:15-38, 2005. 69. Sarter B, Kwok S, Hur G, et al: Potential breast tumor inhibiting
42. Willett WC, Rockhill B, Hankinson SE, et al: Epidemiology and properties of selected natural substances: Effects on hormone-
nongenetic causes of breast cancer. In Harris JR, Lippman ME, mediated growth and function. Presented at the 1st International
Morrow M, et al (eds): Diseases of the Breast. Philadelphia, Conference of the Society of Integrative Oncology, New York,
Lippincott Williams & Wilkins, 2000, pp 175-220. November 17-19, 2004.
43. LeShan L: Cancer as a Turning Point: A Handbook for People with 70. Seely D, Mills EJ, Wu P, et al: The effects of green tea consumption on
Cancer, Their Families, and Health Professionals, rev ed. New York, incidence of breast cancer and recurrence of breast cancer: A systematic
Plume, 1990. review and meta-analysis. Integr Cancer Ther 4:144-155, 2005.
44. Temoshok LR: Rethinking research on psychosocial interventions in 71. Bounous G: Whey protein concentrate (WPC) and glutathione
biopsychosocial oncology: An essay written in honor of the scholarly modulation in cancer treatment. Anticancer Res 20:4785-4792, 2000.
contributions of Bernard H. Fox. Psychooncology 13:460-467, 2004. 72. Marshall K: Therapeutic applications of whey protein. Altern Med
45. Baltrusch HF, Strangel W, Titze I: Stress, cancer and immunity: New Rev 9:136-156, 2004.
developments in biopsychosocial and psychoneuroimmunologic 73. Borchers AT, Keen CL, Gershwin ME: Mushrooms, tumors, and
research. Acta Neurol (Napoli) 13:315-327, 1991. immunity: An update. Exp Biol Med (Maywood) 229:393-406, 2004.
46. Butow PN, Hiller JE, Price MA, et al: Epidemiological evidence 74. Memorial Sloan Kettering Cancer Center: Phase I/III study of mai
for a relationship between life events, coping style, and personality take extract in breast cancer patients. www.mskcc.org/mskcc/html/
factors in the development of breast cancer. J Psychosom Res 2270.cfm?IRBNO-03-107
49:169-181, 2000. 75. Berube S, Diorio C, MasseB, et al: Vitamin D and calcium intakes
47. Kruk J, Abdoul-Enein HY: Psychological stress and the risk of from food or supplements and mammographic breast density.
breast cancer: A case-control study. Cancer Detect Prev 28:399-408, Cancer Epidemiol Biomarkers Prev 14:1653-1659, 2005.
2004. 76. Vasquez A, Manso G, Cannell J: The clinical importance of vitamin
48. Myss C: Anatomy of the Spirit. New York, Three Rivers Press, 1996. D (cholecalciferol): A paradigm shift with implications for all
49. Mokbel K: Risk-reducing strategies for breast cancer: A review of healthcare providers. Integr Med 3:44-55, 2004.
recent literature. Int J Fertil Womens Med 48:274-277, 2003. 77. Natural Standard Research Collaboration:•An evidence-based
50. Dunn BK, Wickerham DL, Ford LG: Prevention of hormone-related systematic review of vitamin D. www.naturalstandard.com/
cancers: Breast cancer. J Clin Oncol 23:357-367, 2005. 78. Sato R, Helzlsourer KJ, Alberg AJ, et al: Prospective study of
51. Greenwald P: Clinical trials in cancer prevention: Current results carotenoids, tocopherols, and retinoid concentrations and the risk of
and perspectives for the future. J Nutr 134:3507S-3512S, 2004. breast cancer. Cancer Epidemiol Biomarkers Prev 11:451-457, 2002.
52. Brew CT, Aronchik I, Hsu JC, et al: Indole-3-carbinol activates the 79. Fairfield KM, Fletcher RH: Vitamins for chronic disease prevention
ATM signaling pathway independent of DNA damage to stabilize in adults: Scientific review. JAMA 287:3116-3126, 2002.
p53 and induce G1 arrest of human mammary epithelial cells. Int J 80. Natural Standard Research Collaboration:•An evidence-based
Cancer 118:857-868, 2006. systematic review of melatonin. www.naturalstandard.com/